Yale Brain Cancer Experts Available to Comment on Malignant Gliomas
New Haven, Conn. â€" Yale University brain cancer experts are available to comment on treatments for malignant gliomas, the type of brain cancer Sen. Edward Kennedy has been diagnosed with.
(Media-Newswire.com) - New Haven, Conn. — Yale University brain cancer experts are available to comment on treatments for malignant gliomas, the type of brain cancer Sen. Edward Kennedy has been diagnosed with. They include:
W. Mark Saltzman, the Goizueta Foundation Professor of Chemical and Biomedical Engineering at Yale, is one of the developers of Gliadel, one of the most commonly used chemotherapy agents used to treat gliomas. Giladel is a slow-release chemo-infused wafer that neurosurgeons leave in place on the surface of the brain after surgery.
Cell: 203-314-3975 Office: 203-432-4262 or 203-432-3281 E-mail: mark.saltzman@yale.edu
Joachim Baehring, M.D. Director of the Yale Cancer Center Brain Tumor Center Assistant professor of neurology and neurosurgery at Yale School of Medicine
This story was released on 2008-05-22. Please make sure to visit the official company or organization web site to learn more about the original release date. See our disclaimer for additional information.